Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,241 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05744921RecruitingPhase 3
Pozelizumab plus cemdisiran for adult PNH over the long term
This Phase 3 study tests whether long-term treatment with pozeli(z)umab plus cemdisiran is safe and works well in adults with paroxysmal nocturnal hemoglobinuria (PNH). It is mainly for people whose PNH does not respond to certain standard medicines or who have genetic changes that make them refractory.
São PauloAges 18 years+ - NCT05710692RecruitingPhase 2/Phase 3
Study drug PRX-102 for Fabry disease in Japanese patients
This trial tests whether PRX-102 is safe and effective for treating Fabry disease in Japanese participants. It also measures how the drug moves through the body and affects body systems, to see if it helps your symptoms and organ function.
Chikushino-shi, FukuokaAges 13–70 - NCT05714293Enrolling by invitation
CT measurements after surgical aortic valve replacement
This study uses a CT scan (with contrast dye) to measure the coronary artery openings after people have a new aortic valve placed surgically. It aims to see how to best plan or understand coronary blood flow after the surgery.
RomaAges 18–80 - NCT05740319Recruiting
Test stool transplant to treat irritable bowel syndrome
This trial studies fecal microbiota transplantation, which is transferring stool bacteria from a healthy donor to help rebalance gut microbes. If you have irritable bowel syndrome (IBS) that hasn’t improved after several standard treatments, this study may see whether it reduces your symptoms and is safe.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT05710627Recruiting
Testing TENEX for hip pain from greater trochanteric pain syndrome
This trial studies whether TENEX (a minimally invasive procedure) can reduce hip pain caused by greater trochanteric pain syndrome (GTPS). It is for people who have tried non-surgical treatments for at least 6 months without enough relief, and who have confirmed GTPS on imaging (MRI or CT).
The Bronx, New YorkAges 30–90 - NCT05722886RecruitingPhase 2/Phase 3
Screening trial for rare cancer gene changes in existing medicines
This trial checks whether existing cancer medicines can help people whose tumors have specific “gene changes” (mutations). You may be assigned to a treatment arm that matches your tumor’s gene results after fresh biopsy and blood testing.
BelfastAges Any age - NCT05714592Recruiting
Optical genome mapping for bone marrow changes in blood cancer
This trial tests whether a special eye-based lab test called optical genome mapping can better detect new (acquired) chromosome changes in people with certain slow-growing blood cancers. It may help doctors choose the right next steps based on what’s happening in the bone marrow.
Amiens, PicardieAges 18 years+ - NCT05714995Recruiting
Aromatherapy plus hypnosis for comfort during cancer care
This trial tests whether aromatherapy (smelling essential oils) combined with hypnosis can improve comfort and well-being for people receiving cancer treatment. It focuses on patients at the start of chemotherapy, along with supportive cancer or palliative care needs.
CréteilAges 18 years+ - NCT05714605Enrolling by invitation
Support program after hospital care for Medicaid patients in Pennsylvania
This trial tests a “health innovation” program that helps Medicaid patients after they leave the hospital and transition to home care. It may help you get support at home so recovery is safer and smoother.
Philadelphia, PennsylvaniaAges 18–99 - NCT05719844Recruiting
Computer tests to assess concussion recovery in young rugby players
This study checks whether a set of computer-based attention and thinking tests can help manage concussion (a brain injury) in young rugby players. It compares players who had a concussion with similarly aged players who haven’t had one.
Clermont-FerrandAges 11–25 - NCT05738187Recruiting
Cryotherapy for repeat head and neck cancer after prior radiation
This pilot study tests whether cooling treatment on the tumor area (cryotherapy) can control a repeat head/neck cancer that can’t be removed and has already been treated with radiation. It also checks safety, especially in areas that have received radiation before.
StrasbourgAges 18 years+ - NCT05739149Recruiting
Ultrasound checks how chronic foot ulcers heal
This study tests a special ultrasound scan to see how chronic diabetic or venous foot ulcers are healing. The goal is to use the scan to better track wound improvement and guide care.
Rochester, MinnesotaAges 18 years+ - NCT05714111Recruiting
Registry for pancreatic cancer patients and people being evaluated
This is a research registry that collects information from adults with suspected or diagnosed pancreatic cancer. It may help doctors better understand the disease and improve care over time.
MilanAges 18 years+ - NCT05743699Recruiting
Bright Horizons program for Native teens with recent binge drinking
This study tests the Bright Horizons program to help Native American youth who recently had a binge alcohol event. It looks at whether support and skills can reduce risky drinking and improve safety and wellbeing.
Whiteriver, ArizonaAges 10–24 - NCT05636527Recruiting
NEXUS aortic arch stent graft safety study
This study checks how safe and well the NEXUS device works for repairing the aorta in the arch area. You may qualify if you need this type of aortic repair and your health supports the procedure.
BrusselsAges 18 years+ - NCT04532489RecruitingEarly Phase 1
PET scan study using a cholesterol-tracking tracer in healthy adults
This early study tests how well a special PET scan tracer can show cholesterol movement in the body. It is for healthy adults who do not have known adrenal problems, and it aims to collect basic imaging safety and dose information.
Ann Arbor, MichiganAges 18 years+ - NCT04546126RecruitingEarly Phase 1
PET scan study tracking cholesterol movement in your body
This early study uses a special PET scan dye to see how cholesterol moves through the body. It is testing how the imaging works in healthy people and in people with adrenal gland hormone secretion problems, to better understand cholesterol handling.
Ann Arbor, MichiganAges 18 years+ - NCT05702645Recruiting
Down syndrome long-term study after leukemia treatment
This study follows children and young adults with Down syndrome who have survived acute leukemia (ALL or AML) to learn about their longer-term health after treatment ends. It may help families and doctors understand what health problems to watch for and how to provide better follow-up care.
Birmingham, AlabamaAges 6–39 - NCT05691491RecruitingPhase 1/Phase 2
Temozolomide plus M1774 for advanced metastatic cancers
This Phase 1/2 trial tests a combination of temozolomide and M1774 to see how safe it is and whether it can help shrink advanced cancers that have spread. It focuses on certain tumor types and specific biomarker results, and it may be an option if standard treatments have been tried or aren’t possible.
Irvine, CaliforniaAges 18 years+ - NCT05685433Recruiting
Real-world study of eCoin for urgent urine leaks
This study looks at how well eCoin (a device treatment) reduces urgent urine leaks in people with overactive bladder. It’s a “real-world” evaluation, meaning it aims to reflect everyday care after the device is already approved.
Homewood, AlabamaAges 18 years+ - NCT05696626RecruitingPhase 3
Test a new pill plus abemaciclib versus standard therapy
This Phase 3 study compares lasofoxifene plus abemaciclib versus fulvestrant plus abemaciclib for ER-positive, HER2-negative breast cancer that has an ESR1 mutation. It looks for better tumor control in people whose cancer has progressed on hormone therapy (an aromatase inhibitor) and who meet specific safety and testing requirements.
Scottsdale, ArizonaAges 18 years+ - NCT05683418RecruitingPhase 1
Study of a new drug for PIK3CA-mutated HR+ HER2- breast cancer
This early-stage study tests the safety and tolerability of TOS-358 in women with HR-positive, HER2-negative breast cancer that has a specific gene change (PIK3CA). It may help learn whether this targeted treatment is safe enough to move forward.
Chicago, IllinoisAges 18 years+ - NCT05696561Recruiting
Testing a glaucoma procedure called canaloplasty device
This trial studies whether a canaloplasty device is safe and effective for people with open-angle glaucoma who are planning cataract surgery. It may help lower eye pressure when using eye drops is being reduced or stopped.
SantiagoAges 22 years+ - NCT05686278Recruiting
Study of long-term outcomes after hip hemiarthroplasty
This is an observational study that follows people over time after hip hemiarthroplasty (a partial hip replacement). It aims to understand how well Corin hip devices work long-term in everyday care, and what outcomes to expect.
Amboise, FranceAges 18 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,241 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.